Active Ingredient (In Each Tablet)
Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)
The following Structured Product Label (SPL) was submitted to the FDA by Supervalu Inc. for the product Ranitidine (NDC 41163-353). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, do not use, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)
Acid reducer
Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers
Ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
Colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol 400, talc, titanium dioxide
Call 1-877-932-7948
NDC 41163-353-31
EQUALINE
Compare to Zantac 75®Active Ingredient*
Acid Reducer
ranitidine Tablets, USP 75 mg
(acid reducer)
prevents & relieves heartburn associated with acid indigestion & sour stomach
30 tablets
DISTRIBUTED BY: SUPERVALU INC.
5115091 03/15
* Please review the disclaimer below.